Insider Trading activities of Aralez Pharmaceuticals Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aralez Pharmaceuticals Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aralez Pharmaceuticals Inc. since year 2005. Table 2 shows the detailed insider transactions of Aralez Pharmaceuticals Inc. since 2005. The reporting company's ticker symbol is ARLZ. The reporting company's CIK number is 1660719.
The total value of stock buying since 2005 is $4,067,310.
The total value of stock sales since 2005 is $17,335,394.
The total value of stock option exercises since 2005 is $541,927.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aralez Pharmaceuticals Inc. (ARLZ).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 9,960 $24,919 0 $0
2017-07 0 $0 10,804 $13,505 0 $0
2017-06 65,000 $75,725 169,626 $217,344 0 $0
2017-05 0 $0 388,685 $558,918 0 $0
2017-03 589,750 $1,440,746 13,030 $31,402 0 $0
2016-11 31,000 $148,080 124,778 $616,156 124,778 $489,129
2016-09 295,929 $1,732,664 150,000 $873,150 0 $0
2016-06 0 $0 0 $0 4,365 $12,309
2016-05 189,500 $670,095 0 $0 0 $0
2016-03 0 $0 2,400,000 $15,000,000 0 $0
2016-02 0 $0 0 $0 8,143 $40,489

Table 2. Detailed insider stock purchases, sales, and option exercises of Aralez Pharmaceuticals Inc. insiders (ARLZ)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-02 Tursi James Patrick (Chief Medical Officer) Sale 9,960 2.50 24,919
2017-07-28 Charles Scott J (Chief Financial Officer) Sale 10,804 1.25 13,505
2017-06-23 Trachtenberg Eric (GC, CCO & Secretary) Sale 7,720 1.33 10,267
2017-06-15 Kirsch Arthur S (Director) Buy 15,000 1.15 17,175
2017-06-14 Kirsch Arthur S (Director) Buy 50,000 1.17 58,550
2017-06-05 Koven Andrew I (President & Chief Business Officer) Sale 161,906 1.28 207,077
2017-05-23 Aryeh Jason (Director) Sale 104,176 1.41 146,888
2017-05-22 Aryeh Jason (Director) Sale 233,468 1.42 332,458
2017-05-19 Aryeh Jason (Director) Sale 51,041 1.56 79,572
2017-03-20 Charles Scott J (Chief Financial Officer) Sale 5,205 2.41 12,544
2017-03-20 Koven Andrew I (President & Chief Business Officer) Sale 7,825 2.41 18,858
2017-03-15 Tursi James Patrick (Chief Medical Officer) Buy 4,750 2.11 10,022
2017-03-15 Kirsch Arthur S (Director) Buy 45,000 2.27 102,239
2017-03-15 Koven Andrew I (President & Chief Business Officer) Buy 20,000 2.55 50,920
2017-03-15 Adams Adrian (Chief Executive Officer) Buy 500,000 2.46 1,231,000
2017-03-15 Lee Kenneth B Jr (Director) Buy 5,000 2.52 12,620
2017-03-15 Rudnick Seth (Director) Buy 15,000 2.26 33,945
2016-11-29 Harris Robert Paul (Director) Sale 104,778 4.99 523,156
2016-11-29 Harris Robert Paul (Director) Option Ex 104,778 3.92 410,729
2016-11-28 Harris Robert Paul (Director) Sale 20,000 4.65 93,000
2016-11-28 Harris Robert Paul (Director) Option Ex 20,000 3.92 78,400
2016-11-14 Lee Kenneth B Jr (Director) Buy 1,000 4.95 4,950
2016-11-11 Rudnick Seth (Director) Buy 30,000 4.77 143,130
2016-09-16 Aryeh Jason (Director) Buy 295,929 5.86 1,732,664
2016-09-15 Harris Robert Paul (Director) Sale 150,000 5.82 873,150
2016-06-13 Thrasher Francis Martin (Director) Option Ex 4,365 2.82 12,309
2016-05-16 Trachtenberg Eric (GC, CCO & Secretary) Buy 10,000 3.76 37,570
2016-05-16 Tursi James Patrick (Chief Medical Officer) Buy 4,500 3.79 17,037
2016-05-16 Glickman Mark A (Chief Commercial Officer) Buy 25,000 3.68 92,050
2016-05-13 Lee Kenneth B Jr (Director) Buy 1,000 3.50 3,500
2016-05-12 Charles Scott J (Chief Financial Officer) Buy 50,000 3.49 174,500
2016-05-12 Kirsch Arthur S (Director) Buy 27,500 3.49 95,975
2016-05-12 Koven Andrew I (President & Chief Business Officer) Buy 71,500 3.49 249,463
2016-03-17 Qlt Inc/bc (10% Owner) Sale 2,400,000 6.25 15,000,000
2016-02-05 Kirsch Arthur S (Director) Option Ex 6,107 5.97 36,458
2016-02-04 Barnhardt John E (VP, Finance & Administration) Option Ex 2,036 1.98 4,031

Insider trading activities including stock purchases, stock sales, and option exercises of ARLZ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aralez Pharmaceuticals Inc. (symbol ARLZ, CIK number 1660719) see the Securities and Exchange Commission (SEC) website.